EP0770094A4 - Recepteurs modifies lies a des proteines g - Google Patents

Recepteurs modifies lies a des proteines g

Info

Publication number
EP0770094A4
EP0770094A4 EP95922156A EP95922156A EP0770094A4 EP 0770094 A4 EP0770094 A4 EP 0770094A4 EP 95922156 A EP95922156 A EP 95922156A EP 95922156 A EP95922156 A EP 95922156A EP 0770094 A4 EP0770094 A4 EP 0770094A4
Authority
EP
European Patent Office
Prior art keywords
modified
protein coupled
coupled receptors
receptors
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95922156A
Other languages
German (de)
English (en)
Other versions
EP0770094A1 (fr
Inventor
Catherine D Strader
Candelore Maria-Luisa Rios
Xiaoming Guan
Richard Dixon
George Mcallister
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0770094A1 publication Critical patent/EP0770094A1/fr
Publication of EP0770094A4 publication Critical patent/EP0770094A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP95922156A 1994-06-29 1995-06-02 Recepteurs modifies lies a des proteines g Withdrawn EP0770094A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26814794A 1994-06-29 1994-06-29
US26798794A 1994-06-29 1994-06-29
PCT/US1995/006900 WO1996000739A1 (fr) 1994-06-29 1995-06-02 Recepteurs modifies lies a des proteines g
US267987 1999-03-12
US268147 1999-03-15

Publications (2)

Publication Number Publication Date
EP0770094A1 EP0770094A1 (fr) 1997-05-02
EP0770094A4 true EP0770094A4 (fr) 1999-05-19

Family

ID=26952801

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95922156A Withdrawn EP0770094A4 (fr) 1994-06-29 1995-06-02 Recepteurs modifies lies a des proteines g

Country Status (4)

Country Link
EP (1) EP0770094A4 (fr)
JP (1) JPH10502245A (fr)
CA (1) CA2193809A1 (fr)
WO (1) WO1996000739A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9606126D0 (en) * 1996-03-22 1996-05-22 British Biotech Pharm Biosensors
US7094593B1 (en) 1998-09-01 2006-08-22 Basf Aktiengesellschaft Method for improving the function of heterologous G protein-coupled receptors
EP1112359A2 (fr) * 1998-09-01 2001-07-04 BASF Aktiengesellschaft Expression fonctionnelle amelioree des recepteurs couples a la proteine g
AU2001259743A1 (en) * 2000-05-12 2001-11-26 3-Dimensional Pharmaceuticals, Inc. Gpcr 4-helix and 5-helix bundles
EP2533046A1 (fr) * 2003-04-24 2012-12-12 Tyratech, Inc. Compositions et procédés de régulation d'insectes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001810A1 (fr) * 1990-07-19 1992-02-06 Lerner Michael R Procedes d'identification de composes agissant comme agonistes ou antagonistes sur des proteines impliquees dans la transduction de signaux biologiques

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001810A1 (fr) * 1990-07-19 1992-02-06 Lerner Michael R Procedes d'identification de composes agissant comme agonistes ou antagonistes sur des proteines impliquees dans la transduction de signaux biologiques

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JIN H. ET AL.: "Characterization of the human 5-hydroxytryptamine 1B receptor", J. BIOL. CHEM., vol. 267, no. 9, 25 March 1992 (1992-03-25), pages 5735 - 5738, XP002096624 *
See also references of WO9600739A1 *
STRADER C.D. ET AL.: "Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity.", J. BIOL. CHEM., vol. 262, no. 34, 5 December 1987 (1987-12-05), pages 16439 - 16443, XP002096623 *

Also Published As

Publication number Publication date
CA2193809A1 (fr) 1996-01-11
JPH10502245A (ja) 1998-03-03
EP0770094A1 (fr) 1997-05-02
WO1996000739A1 (fr) 1996-01-11

Similar Documents

Publication Publication Date Title
HU9603525D0 (en) Vironectin receptor antagonists
HU9601529D0 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists
EP1007536A4 (fr) Nouveau recepteur couple a la proteine g humaine
GB9526131D0 (en) Recombinant chimeric receptors
EP0791009A4 (fr) Recepteurs neuropeptidiques y modifies
HU9603082D0 (en) Neurokinine (tachykinine) antagonists
GB2307356B (en) Coupled line element
EP0817800A4 (fr) Recepteurs couples par une proteine-g humaine
EP0951532A4 (fr) Agonistes bivalents pour recepteurs couples aux proteines g
GB9416554D0 (en) Glutamate receptor
HU9601176D0 (en) Adhesion-receptor antagonists
EP0832125A4 (fr) Recepteur hgber32 de proteine g humaine
GB9826359D0 (en) Novel receptors
EP0871667A4 (fr) Recepteur couple a la proteine g
EP0994900A4 (fr) Recepteurs de semaphorine
GB9517098D0 (en) Receptor
HU9503191D0 (en) Adhesion-receptor antagonists
AU1535699A (en) Novel receptors opg-2
EP0832122A4 (fr) Recepteur hpraj70 de proteine g humaine
EP0832126A4 (fr) Htnad29 recepteurs de proteines g
EP0770094A4 (fr) Recepteurs modifies lies a des proteines g
HU9600333D0 (en) Adhesive receptor antagonists
EP0835264A4 (fr) Hcegh45, recepteur de proteines g humaines
EP0836621A4 (fr) Nouveau recepteur couple a la proteine g humaine
EP0773959A4 (fr) Recepteur adrenergique

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970129

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

RHK1 Main classification (correction)

Ipc: C12N 15/63

A4 Supplementary search report drawn up and despatched

Effective date: 19990401

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 20011023

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020503